ArticlePDF Available

Abstract and Figures

Intrauterine adhesion (IUA) formation and the resulting Asherman's syndrome (AS) is an unfortunate clinical condition that occurs when the endometrium is damaged as a consequence of trauma, such as vigorous curettage, infection, or some Müllerian anomaly. The most frequent symptoms include hypo/amenorrhea, infertility, and adverse reproductive outcomes. Prevention of IUA formation is essential; however, when present, accurate diagnosis and surgical intervention (hysteroscopic adhesiolysis) are required. The outcome of this treatment is based on the technique and the extent of surgery performed which depends on the severity and complexity of the disease. Hence its classification becomes particularly important to determine a standardized therapy for each case and patient counseling regarding the prognosis. In this article, we aim to describe the IUAs classification systems that have been proposed comparing the merits and demerits of each one.
Content may be subject to copyright.
Full Terms & Conditions of access and use can be found at
https://www.tandfonline.com/action/journalInformation?journalCode=imit20
Minimally Invasive Therapy & Allied Technologies
ISSN: (Print) (Online) Journal homepage: https://www.tandfonline.com/loi/imit20
Classification systems of Asherman’s syndrome.
An old problem with new directions
Rahul Manchanda, Aayushi Rathore, Jose Carugno, Luigi Della Corte, J. A. N.
Tesarik, Péter Török, George Angelos Vilos & Salvatore Giovanni Vitale
To cite this article: Rahul Manchanda, Aayushi Rathore, Jose Carugno, Luigi Della Corte, J. A.
N. Tesarik, Péter Török, George Angelos Vilos & Salvatore Giovanni Vitale (2021): Classification
systems of Asherman’s syndrome. An old problem with new directions, Minimally Invasive Therapy
& Allied Technologies, DOI: 10.1080/13645706.2021.1893190
To link to this article: https://doi.org/10.1080/13645706.2021.1893190
Published online: 04 Mar 2021.
Submit your article to this journal
View related articles
View Crossmark data
REVIEW ARTICLE
Classification systems of Ashermans syndrome. An old problem with
new directions
Rahul Manchanda
a
, Aayushi Rathore
b
, Jose Carugno
c
, Luigi Della Corte
d
, J. A. N. Tesarik
e
,
P
eter T
or
ok
f
, George Angelos Vilos
g
and Salvatore Giovanni Vitale
h
a
Gynaecology Endoscopy Unit, PSRI Hospital, New Delhi, India;
b
VMMC & Safdarjang Hospital, New Delhi, India;
c
Department of
Obstetrics, Gynecology, and Reproductive Sciences, University of Miami Miller School of Medicine, Miami, FL, USA;
d
Department of
Neurosciences and Reproductive Sciences, School of Medicine, University of Naples Federico II, Naples, Italy;
e
MARGen Clinic,
Granada, Spain;
f
Faculty of Medicine, Institute of Obstetrics and Gynaecology, University of Debrecen, Debrecen, Hungary;
g
Department of Obstetrics and Gynecology, The Fertility Clinic, London Health Sciences Centre, Western University, London, ON,
Canada;
h
Department of General Surgery and Medical Surgical Specialties, Obstetrics and Gynecology Unit, University of Catania,
Catania, Italy
ABSTRACT
Intrauterine adhesion (IUA) formation and the resulting Ashermans syndrome (AS) is an unfortu-
nate clinical condition that occurs when the endometrium is damaged as a consequence of
trauma, such as vigorous curettage, infection, or some M
ullerian anomaly. The most frequent
symptoms include hypo/amenorrhea, infertility, and adverse reproductive outcomes. Prevention
of IUA formation is essential; however, when present, accurate diagnosis and surgical interven-
tion (hysteroscopic adhesiolysis) are required. The outcome of this treatment is based on the
technique and the extent of surgery performed which depends on the severity and complexity
of the disease. Hence its classification becomes particularly important to determine a standar-
dized therapy for each case and patient counseling regarding the prognosis. In this article, we
aim to describe the IUAs classification systems that have been proposed comparing the merits
and demerits of each one.
ARTICLE HISTORY
Received 7 December 2020
Accepted 16 February 2021
KEYWORDS
Ashermans syndrome;
intrauterine adhesions;
hysteroscopy; classifica-
tion system
Introduction
Intrauterine adhesions (IUAs) were first described by
Heinrich Fritsch in 1894 in a patient who developed
secondary amenorrhea after a postpartum curettage
[1]. In 1948, Joseph Asherman of the Hadassah
Hospital of Tel Aviv published the first article on the
pathology of this condition which he named
Amenorrhoea Traumatica[2]. He described in detail
the etiology, anatomy, differential diagnosis, and
prognosis of this disease. Later, in 1950, he also
described a treatment by laparotomy and the use of
intrauterine catheters to prevent its recurrence [3].
Currently, the term IUAs is often used inter-
changeably with Ashermans syndrome (AS).
Nevertheless, while IUAs defines the presence of
fibrotic bands or synechiae formed between the uter-
ine walls, AS is a spectrum which encompasses the
clinical manifestations of this disease including men-
strual dysfunction, cyclical abdominal pain, infertility,
and poor reproductive outcomes, as well as the ana-
tomical distortion caused by these synechiae.
Endometrial injury (especially of the gravid uterus)
leads up to the development of AS as damage to the
basal layer of the endometrium results in its subse-
quent replacement with the fibrous tissue generating
intrauterine adhesions [4]. The most common causes
contributing to the development of AS include curet-
tage of the postpartum or post abortus uterus, some
M
ullerian anomalies, infections, uterine surgeries, and
the utilization of compressive sutures for postpartum
hemorrhage [5].
The purpose of this review is to describe the vari-
ous classification systems of AS that have been pro-
posed over the years and to compare the merits and
demerits of each one.
Material and methods
The data research was carried out using the following
databases MEDLINE, EMBASE, Web of Sciences,
Scopus, and Cochrane Library querying for all articles
related to AS from the inception of the database up
CONTACT Rahul Manchanda drrahulmanchanda@rediffmail.com Gynaecology Endoscopy Unit, PSRI Hospital, New Delhi, India
ß2021 Society of Medical Innovation and Technology
MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES
https://doi.org/10.1080/13645706.2021.1893190
to September 2020. Studies describing classification
systems of this condition were selected for analysis.
Results
Diagnosis of Ashermans syndrome
Hysterosalpingography (HSG)
Historically, the diagnosis of AS was primarily made
using radiographic techniques such as
Hysterosalpingogram (HSG). The findings suggestive
of AS on HSG are as follows:
Marginal or centrally located intrauterine fill-
ing defects
Partial obliteration of the uterine cavity
Complete distortion of the uterine cavity
Absence of contrast filling inside the uterine cavity
(due to lower uterine cavity obliteration)
Although HSG is an invasive investigation, its role
is of particular importance in cases of infertility asso-
ciated with AS because of its ability to demonstrate
tubal patency as well as tubal contour. The drawback
of HSG is that it is not useful in cases of lower uter-
ine cavity adhesions, given the inability to fill the
endometrial cavity with contrast solution. The sensi-
tivity of HSG is 75% in the detection of IUAs while
its positive predictive value (PPV) is 50% [6].
Ultrasound
Ultrasonography (USG) is a non-invasive diagnostic
investigation that is commonly used as the first-line
diagnostic imaging modality in symptomatic patients
with gynecologic pathology. IUAs appear as dense
echoes within the endometrial cavity with an irregu-
lar, thin endometrium. USG is especially useful in
women with dense lower uterine cavity adhesions
where the role of HSG is limited. The sensitivity and
specificity of transvaginal USG are 52% and 11%,
respectively. Currently, 3D USG is also used to detect
IUAs with a specificity of 45% [6,7].
Sonohysterography
Sonohysterography (SHG) combines the advantages
of both HSG and USG. In this procedure, saline solu-
tion is instilled into the uterus to distend the endo-
metrial cavity. The visualization of echogenic areas
within the saline-filled cavity denotes the presence of
IUAs. The sensitivity of SHG has been reported to be
75% and PPV of 42.9%, which is comparable to that
of HSG [6].
MRI
Magnetic resonance imaging (MRI) is another non-
invasive imaging modality that can be used in cases
of suspected AS. It is frequently used in cases of
dense adhesions as it can evaluate the uterine cavity
above the adhesions and thus helps in the evaluation
of post-treatment prognosis of the disease. It is also
useful in cases where the diagnosis of AS is difficult
using HSG and USG due to dense adhesions and
lower uterine cavity obliteration. Low-intensity signals
on T2 weighted images reveal the presence of IUAs
on MRI. However, its role in routine clinical practice
remains limited because of its high cost [6].
Hysteroscopy
Hysteroscopy is currently the gold standard diagnostic
and therapeutic modality for the diagnosis of AS, gener-
ating only minimal patient discomfort, and allowing the
accurate diagnosis and treatment in only one interven-
tion in an office setting in selected cases, thus improv-
ing patient compliance and cost-effectiveness [8].
Management of Ashermans syndrome
Surgical management, performing intrauterine lysis of
adhesions, is the cornerstone therapy for patients
diagnosed with AS. Joseph Asherman in his initial
reports described how a simple dilatation and curet-
tage (D&C) of the endometrial cavity resolved the
symptoms of abnormal menstruation in the majority
of the cases. Later, he also described that laparotomy
could also be used for its treatment. However, with
the introduction of minimally invasive surgeries, hys-
teroscopic lysis of intrauterine adhesions, over the
years, has gained popularity and is now the gold
standard treatment of AS.
Post-operative adjuvant therapies to prevent refor-
mation of adhesions include the use of barriers such
as inert intrauterine devices, Foleys catheter, hyalur-
onic acid gel with or without the addition of estro-
gen-based medical treatments. Once adhesiolysis is
performed, the patient undergoes a second-look hys-
teroscopy after the next menstrual cycle [6]. The
second-look hysteroscopy is not only diagnostic, but
also allows the treatment of newly formed adhesions.
It could be repeated several times, if needed to pre-
vent more dense adhesion forming [9].
Classification of Asherman syndrome
The prognosis of AS relies on the severity of the con-
dition determined by both the degree of distortion of
2 R. MANCHANDA ET AL.
the uterine cavity and the severity of associated symp-
toms. Hence, an appropriate classification of this dis-
ease was deemed necessary. Initially, the classification
systems were only based on the severity of the intra-
uterine adhesions, but it was soon realized that it was
essential to create a more holistic categorization sys-
tem which also included clinical symptoms. This also
helped in directing the efforts towards standardization
of classification systems for easy global comparison of
findings and success of therapy. However, the search
for an ideal classification system is still ongoing and
further validation is required through large-scale
observational and randomized studies to determine
the most appropriate classification system.
The classification systems developed to date are
listed chronologically in Table 1. They comprise an
HSG-based classification system (Toaff and Ballas,
1978), hysteroscopy-based classification systems
(March classification, 1978, Hamou classification,
1983, Valle classification, 1988, Donnez and Nisolle
classification, 1994, Manchanda Endoscopy classifica-
tion, 2016), and clinico-hysteroscopic classification
systems (American Fertility Society [AFS] classifica-
tion, 1988, European Society of Hysteroscopy [ESH]
classification, 1989, Nasr classification, 2000).
In their 2017 Guidelines for Classification of AS,
the American Association of Gynecologic
Laparoscopists (AAGL) and the European Society for
Gynecological Endoscopy (ESGE) stated that
there was the need for a classification system of
intrauterine adhesions because the severity of this
condition affects the prognosis (Level B);
the different available classification systems com-
pared studies difficult to analyze. This could reflect
inherent deficiencies in each of the classification
systems. Consequently, it is currently not possible
to endorse any specific system (Level C) [10].
Classification based on HSG
Toaff and Ballas classification. Toaff and Ballas were
the first to classify AS in 1978 [11]. An HSG was per-
formed in all patients with suspected AS. They classify
the cases of AS as follows:
Grade 1: a single, small, filling defect within the
uterine cavity, occupying up to about one-tenth
(1/10) of the uterine cavity.
Grade 2: a single, medium-sized filling defect
occupying one-fifth (1/5) of the uterine cavity, or
several smaller defects adding up to the same
degree of involvement, located within the uterine
cavity, whose outline may show minor indenta-
tions but no gross deformation.
Grade 3: a single, large or several smaller, filling
defects involving up to about one-third (1/3) of
the uterine cavity, which is distorted or asymmet-
rical due to marginal adhesions.
Grade 4: large-sized filling defects occupying most
of the severely deformed uterine cavity.
The authors correlated these radiographic findings
with the degree of menstrual dysfunction in 64 patients
and graded the menstrual pattern of patients as:
1:slight, but noticeable reduction in quantity and
duration of the menstrual flow.
11:reduction in menstrual flow quantity and
duration to half of the usual flow.
111:scant menstrual flow for 1 or 2 d followed
by brown spotting
1111:only brown spotting for 1 or 2 d
Table 1. Classification systems for Ashermans syndrome/intrauterine adhesions (IUAs).
Classification Year Summary of classification
Toaff and Ballas 1978 Classifies the IUAs into four grades based on HSG findings to determine the impact of the extent
of IUA as well as their location in the uterus on the menstrual pattern of patients
March 1978 IUA were classified as minimal, moderate, or severe based on hysteroscopic assessment of the
degree of uterine cavity involvement
Hamou 1983 IUAs were classified as isthmic, marginal, central, or severe based on hysteroscopic assessment
Valle 1988 IUAs were classified as mild, moderate or severe based on hysteroscopic assessment and extent
of occlusion (partial or total) at HSG
American Fertility Society 1988 Complex scoring system of mild, moderate and severe IUAs based on extent of endometrial
cavity obliteration, appearance of adhesions, and patient menstrual characteristics based on
hysteroscopy or HSG assessment
European Society for Hysteroscopy 1989 Complex system classifies IUAs as grades I through IV with several subtypes based on a
combination of hysteroscopic and HSG findings and clinical symptoms
Donnez and Nisolle 1994 IUAs were classified into six grades based on their location determined by hysteroscopy or HSG
and postoperative pregnancy rate being the primary clinical outcome
Nasr 2000 Complex system generating a prognostic score by incorporating menstrual and obstetric history
with findings at hysteroscopic assessment
MEC 2016 Simple and easy to use system dividing AS into mild, moderate, and severe grade based on the
extent of uterine involvement at hysteroscopy
MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES 3
In this case series the following correlation
was drawn:
Grade 1 adhesions: asymptomatic, fortuit-
ous findings
Grade 2 adhesions: mostly asymptomatic, in some
cases results in moderate to severe hypo-menorrhea
Grade 3 and Grade 4 adhesions: always symptom-
atic and cause severe menstrual dysfunction.
In light of this, it was understood that the HSG-
based classification system could be useful to correlate
the degree of menstrual dysfunction with the severity
of intrauterine adhesions.
Hysteroscopy-based classification systems
Over the subsequent years, there was an increase use
of hysteroscopy when IUAs were suspected, for both
diagnostic and therapeutic purposes with the advan-
tage of direct visualization of the uterine cavity as
compared to other diagnostic imaging modalities.
Hence hysteroscopy-based classification systems were
subsequently developed.
March classification. The first attempt to classify
IUAs based on hysteroscopic findings was made by
March et al. in 1978. The extent of adhesions present
in the endometrial cavity and the degree of its occlu-
sion was used to grade the severity of AS. They cate-
gorized them into minimal, moderate, and severe.
This classification system is still used because it is
simple to use and easy to remember (Table 2). It is
important to highlight that hysteroscopy-based classi-
fication systems are better to compare the efficacies of
various techniques used for adhesiolysis which was
assessed by performing a second look hysteroscopy.
Thus, the comparison of postoperative outcomes of
such techniques was much easier and convenient.
However, the shortcoming of this classification sys-
tem is that there is no correlation with clinical symp-
toms and the post-treatment success was not
defined [12].
Hamou classification system. In 1983, the concept of
hysteroscopy-based classification system was further
refined by Hamou et al., who also included the extent
and histologic nature of the adhesions as well as the
evaluation of the surrounding glandular endometrium
along with the degree of cavity distortion. They used a
micro-hysteroscope (4 mm diameter and 30-degree
fore-oblique lens) with CO
2
distension media for adhe-
siolysis. After examining the endometrial cavity with a
panoramic view of the uterine cavity and determining
the amount of uterine cavity affected with adhesions,
contact hysteroscopy was done for assessment of size
and histologic nature of adhesions under 20magnifi-
cation. The thickness, extension, and glandular epithe-
lium of the surrounding endometrium were also
visualized under 60and 150magnification (after
methylene blue staining) (Table 3)[13].
The three different types of adhesions described in
his study are as follows:
Endometrial adhesions: white, vascularization simi-
lar to the surrounding endometrium
Fibrous or connective tissue adhesions: transpar-
ent, bridge-like and poorly vascularized
Myometrial adhesions: highly vascular and exten-
sive adhesions
Valle classification. In an attempt to reduce the short-
comings of the previous classification systems, in 1988,
Valle et al. suggested that success of treatment, identified
by improvement in menstrual pattern, and reproductive
outcomes, also had to be correlated with the severity of
disease. They reported that great results were obtained
in cases of mild adhesions and partial occlusion of the
endometrial cavity and less satisfactory results were
achieved with severe adhesions and complete obliter-
ation of the cavity. This classification system thus
included both the extent of endometrial cavity involve-
ment as well as the type of adhesions (Table 4)[14].
The different types of adhesions identified were
as follows:
Mild: filmy adhesions, composed of endometrial
tissue causing partial or complete endometrial cav-
ity occlusion.
Table 2. Detailed classification of Ashermans syndrome by
March, 1978.
Classification Involvement
Severe >3/4 of the uterine cavity involved, agglutination of walls or
thick bands, tubal ostium areas, and upper
cavity occluded
Moderate 1
=
43/4 of the uterine cavity involved, no agglutination of
walls- adhesions only, tubal ostium areas and upper
fundus only partially occluded
Minimal <1/4 of the uterine cavity involved, thin or filmy adhesions,
tubal ostium areas, and upper fundus minimally involved
or clear
Table 3. Classification of Ashermans syndrome by
Hamou, 1983.
Location of the adhesions Isthmic
Marginal
Central
Size of the adhesions <1cm
2
>1cm
2
Type of adhesions Endometrial adhesions
Fibrous/ connective tissue adhesions
Myometrial adhesions
4 R. MANCHANDA ET AL.
Moderate: fibromuscular adhesions, made up of
endometrium causing partial or total occlusion of
the endometrial cavity, can bleed on adhesiolysis.
Severe: dense connective tissue adhesions, lack
endometrial tissue and causing partial or total
occlusion of the endometrial cavity, not likely to
bleed on adhesiolysis.
Donnez and Nisolle classification. In 1994, Donnez
and Nisolle re-emphasized the importance of using
HSG in the classification of AS along with hystero-
scopic finding and proposed a classification system
based on both modalities. They broadly divided AS
into three groups and six subgroups depending on
the type of adhesion and the extent of uterine
involvement as described in Table 5 [15].
MEC classification. In 2016, the Manchandas
Endoscopic Centre (MEC) classification system was
proposed in India, which categorized AS as mild,
moderate, and severe disease owing to the extent of
the endometrial cavity involvement. It encompasses
both dense and flimsy adhesions in all categories. Its
advantage is of being relatively simple and easy to use
in clinical practice [16](Table 6).
The reproductive outcomes based on this classifica-
tion system were correlated with the severity of the
adhesions in a retrospective analysis performed in
2018 by Sharma et al., who reported an increased
number of live births after adhesiolysis in the moder-
ate and severe categories of adhesions. The direction
and degree of adhesiolysis performed by hysteroscopy
were guided by preoperative assessment of myome-
trial thickness of fundal, anterior, and posterior uter-
ine walls using the RRmethod in this study [17].
The RR methodis named after the two main authors
of this paper and refers to the measurement of myo-
metrial thicknesses both at the fundus of the uterus
and at anterior/posterior uterine walls, that guides the
amount and the direction of hysteroscopic adhesioly-
sis [17].
Clinico-hysteroscopic classification
American Fertility Society (AFS) classification.
Historically, the focus has primarily been on how to
make the diagnosis of AS, whereas the presenting
clinical symptoms of patients have been overlooked
and not included in the proposed grading systems. In
1988, the AFS introduced a comprehensive classifica-
tion system that became the most widely accepted
IUAs classification system across the globe. It
included the clinical symptoms (menstrual pattern) as
an indicator of disease severity, which was considered
important as it gives an estimate about the amount of
endometrium which was available for potential regen-
eration post-adhesiolysis and serves as an important
marker for defining the prognosis post-treatment,
thus helping in pre-treatment patient counseling.
Scoring points (13) were given to each of the
included characteristics and staging of AS was done
(stage I/II/III: mild/moderate/severe) according to the
score obtained. Additionally, a prognostic score to
each patient was for the first time assigned by a clas-
sification system and hence it became a more object-
ive way of classification (Table 7)[18].
European Society of Hysteroscopy (ESH). Another
classification system was proposed by the European
Society of Hysteroscopy (ESH) in 1989, incorporating
the menstrual pattern of women with AS. However,
the reproductive outcome of patients, which is one of
the important aspects in cases of AS, was not
included. Another disadvantage of this classification
system was that, despite it being a very comprehen-
sive system for grading, its complexity makes it
Table 4. Classification of Ashermans
Syndrome by Valle, 1988.
Type of adhesion Mild
Moderate
Severe
Extent of uterine cavity occlusion Partial
Total
Table 5. Classification of Ashermans syndrome by Donnez
and Nisolle, 1994.
Degree Location
I Central adhesion
a. Thin filmy adhesion (endometrial adhesions)
a. Myofibrous (connective adhesions)
II Marginal adhesions (always myofibrous or connective)
a. Wedge like projection
a. Obliteration of one horn
III Uterine cavity absent on HSG
a. Occlusion of the internal os (upper cavity normal)
a. Extensive coaptation of the uterine walls
(absence of the uterine cavity, true Ashermans syndrome)
Table 6. MEC classification of Ashermans syndrome.
Grade Category Characteristics
Grade 1 Mild Less than one-third of the uterine cavity is obliterated (filmy/dense adhesions)
Grade 2 Moderate 1/32/3 of the uterine cavity obliterated (filmy/dense adhesions)
Grade 3 Severe More than two-thirds of the uterine cavity obliterated (filmy/dense adhesions)
MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES 5
difficult to remember and use in clinical practice,
thus limiting its utility (Table 8)[19].
Nasr classification. Nasr et al. (2000) described a
very comprehensive scoring system including the clin-
ical symptoms (both menstrual pattern and repro-
ductive outcomes) of the patients and the
hysteroscopic findings along with providing a prog-
nostic correlation. This system gives greater emphasis
on the type of adhesions and the ability to visualize
the tubal ostium over the involvement of the rest of
the endometrial cavity. Adhesions were pathologically
classified into three categories: filmy/dense/tubular.
The latter, which is the most severe form of the dis-
ease, indicates dense adhesions obliterating the entire
uterine cavity, thereby obscuring both the tubal ostia.
Isthmic fibrosis was identified as a separate entity and
was given special importance as it could initiate a
neuroendocrine reflex and cause endometrial deacti-
vation and amenorrhea even when the rest of the cav-
ity is free of adhesions [20].
Prevalent classification adopted in the world
Although a variety of classification systems have been
developed so far to categorize Asherman syndrome,
we could not find any literature on the comparison of
these classification systems in terms of their prognos-
tic significance. The use of HSG to classify Asherman
syndrome has now become obsolete with the begin-
ning of hysteroscopy. Having said that, in our view
clinico-hysteroscopic classification as given by AFS is
currently the best method of classification and is
being widely used in the Indian clinical settings.
Moreover, the hysteroscopic classification given by
March et al. and the recently introduced MEC classi-
fication system remains the most convenient and easy
to remember classifications in operating rooms.
Conclusion
The diagnosis of AS should be taken into account in
case of alterations of the menstrual flow and poor
reproductive outcomes in women with a history of
endometrial trauma. Classifying AS is important
because it represents the basis for understanding how
to manage a patient according to the severity of
the disease.
While previously radiographic findings of HSG
were used to classify this disease, later direct visualiza-
tion of the endometrial cavity by hysteroscopy became
a favored approach and focus was thus shifted to for-
mulate an ideal classification system which should be
both comprehensive and easy to use, including the
disease symptoms along with the extent adhesions
inside the uterine cavity. Although numerous classifi-
cation systems have been proposed over the years, the
search is still ongoing and none of the available classi-
fication systems specify the influence of its severity on
the reproductive outcome. Additionally, these systems
still need to be validated with larger randomized stud-
ies and clinical application of these classification sys-
tems have to be further evaluated.
Main points
Classification systems are necessary to evaluate the
extent of intra-uterine adhesions, selecting the best
treatment option and analyzing the postoperative
success of adhesiolysis.
The various classification systems include HSG-
based classification, hysteroscopy-based classifica-
tion, and clinico-hysteroscopic classification.
HSG-based classifications have become by and
large obsolete.
The most widely accepted among these is the AFS
classification, which is a clinico-hysteroscopic
classification.
Table 7. Classification of Ashermans syndrome by American
Fertility Society (AFS), 1988.
Characteristics
Extent of cavity involved <1/3 <1/32/3 >2/3
12 4
Type of adhesions Flimsy Filmy and Dense Dense
12 4
Menstrual pattern Normal Decreased Amenorrhoea
02 4
Prognostic classification HSG score Hysteroscopy
score
Stage I (Mild) 14
Stage II (Moderate) 58
Stage III (Severe) 912
Table 8. Classification of Ashermans syndrome by European
Society of Hysteroscopy (ESH) 1989.
Grade Extent of intrauterine adhesion
I Thin or filmy adhesion
The adhesions are easily broken using only the
hysteroscope sheath
The cornual areas are normal
II Single firm adhesion
Connecting separate parts of the uterine cavity
Visualization of each tubal ostium is possible
Cannot be broken by hysteroscope sheath alone
IIa Occluding adhesions only in the region of internal cervical os
The upper uterine cavity normal
III Multiple firm adhesions
Connecting separate parts of the uterine cavity
Unilateral obliteration of tubal ostium areas
IIIa Extensive scarring of the uterine cavity with
amenorrhea or decreased menstrual flow
IIIb Combination of III and IIIa
IV Extensive firm adhesions with agglutination of the uterine walls
At least both tubal ostium areas are occluded
6 R. MANCHANDA ET AL.
Nasr has developed the most comprehensive classi-
fication system in 2000, which is the most ideal
one, to include prognostic scoring as well as the
reproductive outcome of the patients.
The most recent classification system has been
developed in 2016 in India, known as MEC classi-
fication, which is hysteroscopy-based and is rela-
tively simple and easy to implement under
clinical settings.
Further clinical studies are required to validate the
clinical application of these classification systems
and to prognosticate post-treatment reproductive
outcomes according to the severity of
the condition.
Declaration of interest
The authors report no conflicts of interest.
ORCID
Rahul Manchanda http://orcid.org/0000-0002-6367-3005
Luigi Della Corte http://orcid.org/0000-0002-0584-2181
Salvatore Giovanni Vitale http://orcid.org/0000-0001-
6871-6097
References
[1] Fritsch H. Ein fall von volligen schwund der gebau-
mutterhohle nach auskratzung. Zentralbl Gynaekol.
1894;18:13371342.
[2] Asherman JG. Amenorrhoea traumatica (atretica). J
Obstet Gynaecol Br Emp. 1948;55(1):2330.
[3] Asherman JG. Traumatic intra-uterine adhesions. J
Obstet Gynaecol Br Emp. 1950;57(6):892896.
[4] Amin TN, Saridogan E, Jurkovic D. Ultrasound and
intrauterine adhesions: a novel structured approach
to diagnosis and management. Ultrasound Obstet
Gynecol. 2015;46(2):131139.
[5] Conforti A, Alviggi C, Mollo A, et al. The manage-
ment of Asherman syndrome: a review of literature.
Reprod Biol Endocrinol. 2013;11:118.
[6] Yu D, Wong YM, Cheong Y, et al. Asherman syn-
drome-one century later. Fertil Steril. 2008;89(4):
759779.
[7] Benacerraf BR. Three-dimensional volume imaging
in gynecology. Obstet Gynecol Clin North Am.
2019;46(4):755781.
[8] Di Guardo F, Della Corte L, Vilos GA, et al.
Evaluation and treatment of infertile women with
Asherman syndrome: an updated review focusing on
the role of hysteroscopy. Reprod Biomed Online.
2020;41(1):5561.
[9] Yang JH, Chen MJ, Wu MY, et al. Office hystero-
scopic early lysis of intrauterine adhesion after trans-
cervical resection of multiple apposing submucous
myomas. Fertil Steril. 2008;89(5):12541259.
[10] AAGL Elevating Gynecologic Surgery. AAGL prac-
tice report: practice guidelines on intrauterine adhe-
sions developed in collaboration With the European
Society of Gynaecological Endoscopy (ESGE). J
Minim Invasive Gynecol. 2017;24:695705.
[11] Wallach E, Toaff R, Ballas S. Traumatic hypomenor-
rhea-amenorrhea (Asherman syndrome). Fertil
Steril. 1978;30(4):379387.
[12] March CM, Israel R, March AD. Hysteroscopic
management of intrauterine adhesions. Am J Obstet
Gynecol. 1978;130(6):653657.
[13] Hamou J, Salat-Baroux J, Siegler AM. Diagnosis and
treatment of intrauterine adhesions by microhystero-
scopy. Fertil Steril. 1983;39(3):321326.
[14] Valle RF, Sciarra JJ. Intrauterine adhesions: hystero-
scopic diagnosis, classification, treatment, and repro-
ductive outcome. Am J Obstet Gynecol. 1988;
158(6 Pt 1):14591470.
[15] Donnez J, Nisolle M. Hysteroscopic lysis of intra-
uterine adhesions (Asherman syndrome). In:
Donnez , editor. Atlas of laser operative laparoscopy
and hysteroscopy. New York (NY): Press-Parthenon;
1994. p. 305322.
[16] Chithra S, Manchanda R, Jain N. Role of hystero-
scopy in diagnosis of Ashermans syndrome: a retro-
spective study. Int J Curr Res. 2016;8:3196331970.
[17] Sharma R, Manchanda R, Chandil N. Revisiting
diagnostic and therapeutic challenges in Ashermans
syndrome: a retrospective analysis of 5 years. Int J
Curr Res. 2018;10:7242972434.
[18] The American Fertility Society classifications of
adnexal adhesions, distal tubal occlusion, tubal
occlusion secondary to tubal ligation, tubal pregnan-
cies, Mullerian anomalies and intrauterine adhe-
sions. Fertil Steril. 1988;49:944955.
[19] Wamsteker K, De Blok SJ. Diagnostic hysteroscopy:
technique and documentation. In: Sutton C, Diamon
M, editors. Endoscopic surgery for gynecologists.
New York (NY): Lippincott Williams & Wilkins
Publishers; 1995. p. 263276.
[20] Nasr AL, Al-Inany H, Thabet S, et al. A clinicohys-
teroscopic scoring system of intrauterine adhesions.
Gynecol Obstet Invest. 2000;50(3):178181.
MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES 7
... Sonohysterography, which combines transvaginal sonography with intrauterine injection of saline solution, has been shown to be superior to transvaginal ultrasonography in the detection of intrauterine adhesions. The visualization of echogenic areas within the saline-filled cavity denotes the presence of intrauterine adhesions [33]. ...
... Saline infusion sonograms with or without 3D assessment are used to assess the uterine cavity for any abnormalities and can also be used for tubal patency assessment [50]. Ultrasound is used to assess endometrium for the presence of polyps and intrauterine adhesions (Asherman's syndrome) [8,32,33,51]. Polycystic ovarian syndrome contributes to female infertility secondary to anovulation and its sonographic findings are discussed above [44]. ...
... 3 Several classification systems have been proposed to categorize intrauterine adhesions; however, most have several drawbacks. 4 Recently, a call for a prognosis-oriented classification system has been voiced by several experts. 4,5 Currently used classification systems are descriptive in different ways and are therefore non-comparable. ...
... 4 Recently, a call for a prognosis-oriented classification system has been voiced by several experts. 4,5 Currently used classification systems are descriptive in different ways and are therefore non-comparable. 6 Only two classification systems include menstrual pattern and obstetric history, three of the classifications are descriptive with three stages: minimal/mild, moderate, and severe based on the hysteroscopic assessment of the extent and type of adhesions (filmy, firm/dense). ...
Article
Full-text available
Objective To propose a new classification system (Urman‐Vitale Classification System) for intrauterine adhesions (IUAs) and to evaluate anatomical and fertility outcomes after hysteroscopic adhesiolysis accordingly. Methods A retrospective analysis of consecutive patients treated over 11 years by a single operator in a tertiary care hospital. Women with sonographic suspicion of IUAs were scheduled for hysterosalpingography (HSG) and hysteroscopy for confirmation and treatment. IUAs were divided into five classes according to symptoms, ultrasound, HSG findings, and postsurgical hysteroscopic appearance. Hysteroscopic adhesiolysis was performed using a bipolar cutting electrode in an office setting. Evaluated outcomes were restoration of the uterine cavity, clinical pregnancy, pregnancy loss, and live birth rates. Results A total of 227 patients (479 procedures) were included. Mean number of hysteroscopies increased in frequency with class of adhesions from Class 1 to Class 5 (1.0 ± 0.2 vs 2.3 ± 0.5; P = 0.001). Full restoration of the cavity was achieved in 100% of patients with Class 1 compared with 18.5% for Class 5 (43/43 vs 5/27; P = 0.001). Clinical pregnancy (Class 1 vs Class 4: P = 0.034; 1 vs 5: P = 0.006; 2 vs 5: P = 0.024) and live birth (Class 1 vs Class 4: P = 0.001; 1 vs 5: P = 0.006; 2 vs 4: P = 0.007; 2 vs 5: P = 0.0208) rates decreased with increasing severity of IUAs. Pregnancy loss rate was related to IUA severity (Class 1 vs Class 4: P = 0.012; 1 vs 5: P = 0.003: 2 vs 4: P = 0.014; 2 vs 5: P = 0.021). Conclusion A classification based on symptoms, imaging findings, and postsurgical macroscopic appearance of the uterine cavity could be useful in predicting prognosis and fertility in women with IUAs.
... Sonohysterography, which combines transvaginal sonography with intrauterine injection of saline solution, has been shown to be superior to transvaginal ultrasonography in the detection of intrauterine adhesions. The visualization of echogenic areas within the saline-filled cavity denotes the presence of intrauterine adhesions [33]. ...
... Saline infusion sonograms with or without 3D assessment are used to assess the uterine cavity for any abnormalities and can also be used for tubal patency assessment [50]. Ultrasound is used to assess endometrium for the presence of polyps and intrauterine adhesions (Asherman's syndrome) [8,32,33,51]. Polycystic ovarian syndrome contributes to female infertility secondary to anovulation and its sonographic findings are discussed above [44]. ...
Chapter
Full-text available
Ultrasound has developed into a vital medical diagnostic tool during the past 60 years. Theodore Dussik and his brother Friederich were the first to utilize ultrasound in the 1930s and 1940s to identify a brain tumor. Ultrasonography is now used for many different situations, such as disease detection, assisting with biopsy taking, monitoring previously diagnosed abnormalities, and assessing pregnancy. Unfortunately, the general public is unaware of the role of ultrasound in women’s health for purposes other than pregnancy assessment. This chapter’s major goal is to give a comprehensive overview of the various roles that ultrasound plays in women’s health. Furthermore, this chapter aims to make the general public more aware of the importance that ultrasound plays in women’s health. The authors used a wide range of sources for this work, such as books and peer-reviewed publications. The key roles of ultrasound examination in women’s health include: assessment of female reproductive organs, determination of causes of infertility, assessment of pregnancy and related problems, and assessment of the breast and abdomen. The general public should be made aware of the importance of ultrasound in women’s health.
... La clasificación de marzo es la más utilizada por su poca complejidad, de acuerdo al grado de afectación de la cavidad uterina clasifica a las adherencias como leves, moderadas y graves (Abbott et al., 2017; Cedars y Adeleye, 2021a). Se consideran AIU leves cuando ocupan menos de un cuarto de la cavidad uterina, son delgadas, transparentes, el ostium tubárico y fondo uterino están mínimamente afectados; las moderadas ocupan entre uno a tres cuartos de la cavidad, el ostium tubárico y parte superior del fondo están parcialmente obstruidos; graves si ocupan más de tres cuartos de la cavidad, la oclusión del ostium tubárico y del fondo superior es completa y hay aglutinación de las paredes uterinas o bandas gruesas (Baradwan et al., 2018;Manchanda et al., 2021). ...
... La ecohisterografía con infusión de solución salina o gel estéril en la cavidad uterina tiene una sensibilidad del 75% y la presencia de áreas ecogénicas indica que existen AIU (Di Guardo et al., 2020). El uso de estos métodos previamente mencionados se limita a la obstrucción completa de la cavidad o a la presencia de adherencias uterinas densas ubicadas en la parte inferior, por lo que en estos casos la resonancia magnética resulta ser una opción favorable (Dreisler y Kjer, 2019;Manchanda et al., 2021). ...
Article
Full-text available
El síndrome de Asherman representa un problema de salud, debido a que ocasiona alteraciones ginecológicas que afectan el ciclo menstrual y la función reproductiva. Actualmente, la histeroscopia utilizada para eliminar las adherencias no logra recuperar la anatomía endometrial por lo que el porcentaje de recurrencias es elevado y la tasa de embarazos es baja, por lo tanto, se necesita de métodos coadyuvantes para evitar o disminuir estas recidivas y mejorar la receptividad. El objetivo de esta revisión bibliográfica fue describir las principales alternativas terapéuticas coadyuvantes empleadas en el manejo postoperatorio de las recidivas del Síndrome de Asherman. Para ello, se realizó una búsqueda en las bases de datos Google Académico, PubMed y Springer, se encontró un total de 898 artículos, se excluyeron aquellos que tenían otras variables de estudio como: aborto, infertilidad, embarazo, los que no disponían de texto completo y aquellos cuya fecha de publicación fue antes del 2017, al final se seleccionaron 32 artículos. Resultados: los estrógenos en combinación con progesterona a dosis bajas ayudan a mejorar la función endometrial, por otro lado, el DIU con ácido hialurónico representa la mejor opción para una buena reparación endometrial. Conclusión: el uso de barreras sólidas combinadas con geles y la terapia hormonal constituye la alternativa de mayor eficacia en el tratamiento de las recidivas del síndrome de Asherman, y los avances en la terapia con células madre garantizan una recuperación total, pero aún existen limitaciones que impiden su uso.
... AS is an acquired disorder characterized by the presence of intrauterine adhesions caused by injury of the basalis layer of the endometrium [34,35]. This leads to a loss of the normal cyclic proliferation and secretions from the endometrium, and usually results in various adverse reproductive outcomes when the uterine cavity is blocked by scarred tissues [36,37]. ...
Article
Full-text available
LAMB3, a major extracellular matrix and basal membrane component, is involved in wound healing. We aimed to understand its role in Asherman’s syndrome (AS), which is associated with infertility, by using bioinformatics analysis and cultured endometrial stromal cells (ESCs). MRNAs extracted from tissues obtained from control subjects and patients with severe intrauterine adhesion were sequenced and subjected to bioinformatics analysis and the RhoA/ROCK1/MYL9 pathway was implicated and this subsequently studied using cultured primary ESCs. The effects of overexpression and knockdown and activation and inhibition of LAMB3 on the mesenchymal to myofibroblastic phenotypic transformation of ECCs were assessed using PCR and western blot analysis. Phalloidin was used to localize the actin cytoskeletal proteins. Silencing of LAMB3 reversed the TGF-β-induced ESC myofibroblast phenotype conversion, whereas overexpression of LAMB3 promoted this process. Activation and silencing of LAMB3 led to remodeling of the ESC cytoskeleton. Overexpression and silencing of LAMB3 caused activation and inhibition of ESCs, respectively. Y-27632 and LPA reversed the activation and inhibition of the RhoA/ROCK1/MYL9 pathway after overexpression and silencing, respectively. These results suggest that LAMB3 can regulate ESC fibrosis transformation and cytoskeleton remodeling via the RhoA/ROCK1/MYL9 pathway. This study provides a potential new target for gene therapy and drug intervention of AS.
Thesis
Full-text available
Amenorrhea is a rare reproductive medicine condition defined by the absence of menstruation during puberty or later life. It is a symptom, not a disease that can cause due to disorders of the hypothalamus and pituitary glands, disorders of sexual glands and deformities of the uterus and ovaries. Inactivating mutations and polymorphism of the follicle-stimulating hormone receptor (FSHR) can cause amenorrhea due to abolishing the receptor’s function by creating a complete block, and changing the receptor-ligand complex or the basic hormone signal transduction to ovarian failure. This study aims to establish the frequency and pattern of chromosomal abnormalities (CA) in both primary amenorrhea (PA) and secondary amenorrhea (SA). Further, to detect the genetic changes in exon 10 at nucleotide positions 919 and 2039 of the genotypes Thr307Ala, and Asn680Ser, respectively. Furthermore, detect the frequency of the presence of inactivating mutations (Ala575Val) at position 1540 of the FSHR gene. This cross-sectional study was conducted on Seventy amenorrhoeic women with well-known Helsinki Declaration rules of medical ethics divided into 40 (57.14%) with PA and SA in 30 (42.86%) while 30 healthy women with regular menstruation as control. The chromosomal karyotyping has been done according to the ISCN, 2020. PCR products were submitted to RFLP and Sanger sequencing for women with normal karyotype (46, XX) and high FSH serum levels. The classical Turner Syndrome was the most common CA in PA followed by isochromosome X [46, Xi(X)(q10)], mosaicism of Turner and isochromosome X [45, X /46, Xi(X)(q10)], sex reversal (46, XY) and (46, XX,- 3,+der3,-19,del 19 p). The abnormal cases of SA were represented by mosaicism Turner syndrome (45, X/46, XX) and (46, XX,-3,+der3, X,+derX). VI The homozygous genotypes AA and GG of Ala307Thr (rs6165) in the FSHR genes are significant between PA and control groups, while homozygous genotype AA is more common in SA. GG and AG genotypes of Ser680Asn (rs6166) are more frequent in patients with PA and SA compared to healthy control women in the Iraqi population. No detected mutation in Ala575Val at position 1540 in all patients with PA and SA. Both PCR-RFLP and Sanger sequencing techniques observe a marked matching between genotypes. The study emphasizes the need for cytogenetic analysis to know the genetic basis of PA and SA. Further, genotyping for women with normal karyotype and high FSH serum concentrations by PCR-RFLP should be considered for the precise diagnosis and the development of appropriate management and counselling of these patients. Also, this study gives the impression that amenorrheic women in the Iraqi population do not have any inactivating mutations in the FSHR gene.
Article
Introduction and importance FIGO (International Federation of Gynecology and Obstetrics) and WHO (World Health Organization) report the incidence of postpartum hemorrhage (PPH) reaches 1-10% and contributes to an increase in postpartum maternal mortality with uterine atony as the most common cause. B-Lynch method is a suturing technique to overcome PPH. Athough this method has proven useful as an emergency life-saving measure, the post-procedure complications are still able to occur. Presentation of case The patient was not menstruating for 14 months after giving birth through caesarean section with B-Lynch due to PPH. Before pregnancy, she had regular menstruation cycle and normal menstrual duration. Her general and gynecological status were normal. Ultrasound showed the impression of uterine hypoplasia and endometrium that were difficult to assess while both ovaries were normal. Diagnostic hysteroscopy showed a severe degree of Asherman’s syndrome. The results of FSH, LH and estradiol were normal. Discussion B-lynch suture is performed as a method to stop PPH in uterine atony. Secondary amenorrhea occurs as a complication of B-lynch. Compression action of B-lynch can cause progressive myometrium necrosis resulting in synechiae and blockade of uterine blood flow. This will interfere with the development of the uterus. Intrauterine adhesions and amenorrhea with normal levels of FSH, LH, and estradiol support the diagnosis of Asherman’s syndrome. Conclusion Our case shows that the B-Lynch procedure, which is the worldwide recommended method for treating postpartum hemorrhage due to its high success rate, can cause complications of Asherman’s syndrome and cause secondary amenorrhea.
Article
Full-text available
El síndrome de Asherman (SA) es causa importante de infertilidad y alteraciones del patrón menstrual. El objetivo de esta revisión fue evaluar la evidencia científica sobre la eficacia del plasma rico en plaquetas en mujeres en edad fértil con síndrome de Asherman para evitar la formación de nuevas adherencias, mejorar la fecundidad y disminuir los síntomas menstruales relacionados. Se recopilaron artículos científicos de bases de datos (PubMed, Google académico, Springer, Wiley online library, Taylor and Francis online, Scopus, Scielo), realizados en mujeres con síndrome de Asherman, sometidas a la infusión de plasma rico en plaquetas (PRP). Se seleccionaron 27 artículos, ocho de ellos están a favor de su uso, ya que demostraron mejoría en la función endometrial, a pesar de no encontrar hallazgos estadísticamente significativos. Mientras que, seis investigaciones recomiendan realizar nuevos ensayos. En conclusión, los estudios analizados en su mayoría recomiendan el empleo de plasma rico en plaquetas en el tratamiento del síndrome de Asherman, ya que disminuyó las recidivas, mejoró las tasas de embarazos y restableció del patrón menstrual. A pesar de que algunos de ellos no encontraron un beneficio evidente, por los mínimos efectos observados, este factor debe investigarse, ya que puede estar influido por variables adicionales.
Article
Full-text available
Introduction Hysteroscopy is a useful procedure for diagnosing endometrial cancer. There is controversy regarding whether hysteroscopy affects the prognosis of endometrial cancer by prompting cancer cell into intraperitoneal dissemination. Our purpose was to confirm whether hysteroscopy could be a risk factor of the tumor stage, recurrence and survival rate of endometrial cancer. Methods This multicenter retrospective study included all consecutive patients who had endometrial carcinoma diagnosed preoperatively with hysteroscopy and directed endometrial biopsy (HSC, group A) and dilatation and curettage (D&C, group B) between February 2014 and December 2018 at the Fujian Provincial, China. We compared the demographic feature, clinical characteristics and prognosis between the two groups. Results A total of 429 patients were included in the study (Group A, n = 77; Group B, n = 352). There was no significant difference between their baseline characteristics [including age, BMI, histological type and International Federation of Gynecology and Obstetrics (FIGO) stage]. By comparing several pathological conditions that may affect prognosis, there were no significant differences between the two groups in the peritoneal cytology, depth of myometrial invasion, the positivity of lymph nodes, lymphovascular space invasion and paraaortic lymph node dissection. Finally, no significant difference was found between the two groups in overall survival (OS) ( P = 0.189) or recurrence free survival (RFS) ( P = 0.787). Conclusion Under certain inflation pressure and distension medium, hysteroscopic examination and lesion biopsy ensure the safety and have no adverse effects on prognosis compared to conventional curettage.
Article
Full-text available
Asherman syndrome is a rare acquired clinical condition resulting in the obliteration of the uterine cavity due to the presence of partial or complete fibrous intrauterine adhesions involving at least two-thirds of the uterine cavity potentially obstructing the internal cervical os. Common reported symptoms of the disease are alterations of the menstrual pattern with decreased menstrual bleeding leading up to amenorrhea and infertility. Hysteroscopy is currently considered the gold standard diagnostic and therapeutic approach of patients with intrauterine adhesions. However, an integrated approach including preoperative, intraoperative and postoperative therapeutic measures are warranted due to the complexity of the syndrome. This review aims to summarize the most recent evidence on the recommended preoperative, intraoperative and postoperative procedures to restore the uterine cavity and a functional endometrium, as well as on the concomitant use of adjuvant therapies to achieve optimal fertility outcomes.
Article
Full-text available
Asherman syndrome is a debatable topic in gynaecological field and there is no clear consensus about management and treatment. It is characterized by variable scarring inside the uterine cavity and it is also cause of menstrual disturbances, infertility and placental abnormalities. The advent of hysteroscopy has revolutionized its diagnosis and management and is therefore considered the most valuable tool in diagnosis and management. The aim of this review is to explore the most recent evidence related to this condition with regards to aetiology, diagnosis management and follow up strategies.
Article
3D ultrasound imaging of the female pelvis is one of the most important recent advances in diagnostic imaging. Volume acquisitions can provide a large number of images of the pelvic organs simultaneously and in any plane or orientation desired. The coronal plane of the uterus is only visible when reconstructed from a volume and is key to imaging the uterus for indications such as uterine anomalies, IUD positioning, locations of fibroids and polyps, or early pregnancies. 3D ultrasonography has huge potential for evaluating infertile patients, performing difficult procedures under guidance, and studying patients with abnormal uterine bleeding, hydrosalpinges, and cancer.